CCM
HZNP

Cinctive Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cinctive Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-238,812
Closed -$27.6M – 543
2023
Q3 		$27.6M Sell
238,812
-26,389
-10% -$2.84M 1.37% 11
2023
Q2 		$27.3M Buy
265,201
+44,201
+20% +$4.66M 0.91% 20
2023
Q1 		$24.1M Buy
221,000
+106,000
+92% +$11.7M 0.8% 16
2022
Q4 		$13.1M Buy
+115,000
New +$9.55M 0.64% 37
2022
Q2 		– Sell
-138,341
Closed -$14.6M – 690
2022
Q1 		$14.6M Buy
138,341
+1,323
+1% +$129K 0.54% 37
2021
Q4 		$14.8M Sell
137,018
-14,217
-9% -$1.55M 0.65% 20
2021
Q3 		$16.6M Buy
151,235
+7,605
+5% +$789K 0.81% 12
2021
Q2 		$13.4M Buy
143,630
+130,935
+1,031% +$12M 0.63% 24
2021
Q1 		$1.17M Buy
+12,695
New +$1.07M 0.07% 321
2020
Q4 		– Sell
-80,595
Closed -$6.26M – 436
2020
Q3 		$6.26M Sell
80,595
-34,723
-30% -$2.39M 0.55% 53
2020
Q2 		$6.41M Sell
115,318
-33,518
-23% -$1.43M 0.74% 24
2020
Q1 		$4.41M Sell
148,836
-36,164
-20% -$1.22M 0.98% 21
2019
Q4 		$6.7M Buy
+185,000
New +$5.67M 0.7% 41

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cinctive Capital Management's HZNP Position: Q4 2023 in Review

Cinctive Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 238,812 shares — an estimated $27.6M sold.

Cinctive Capital Management first reported a position in HZNP in Q4 2019 and held it in 13 quarters. The position peaked at $27.6M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Cinctive Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cinctive Capital Management sold 238,812 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $27.6M.
  • Cinctive Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 13 quarters.
  • Cinctive Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $27.6M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Cinctive Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.